China Jo-Jo Drugstores Inc is a pharmaceutical retailers business based in the US. China Jo-Jo Drugstores shares (CJJD) are listed on the NASDAQ and all prices are listed in US Dollars. China Jo-Jo Drugstores employs 1,001 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $0.35 |
|---|---|
| 52-week range | $0.35 - $1.68 |
| 50-day moving average | $0.47 |
| 200-day moving average | $0.75 |
| Wall St. target price | $7.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.20 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.35 from 2022-01-21
| 1 week (2022-01-14) | -2.78% |
|---|---|
| 1 month (2021-12-23) | -10.26% |
| 3 months (2021-10-22) | -44.44% |
| 6 months (2021-07-23) | -58.82% |
| 1 year (2021-01-22) | -70.83% |
|---|---|
| 2 years (2020-01-24) | -81.77% |
| 3 years (2019-01-24) | 2.19 |
| 5 years (2017-01-24) | 1.83 |
Valuing China Jo-Jo Drugstores stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China Jo-Jo Drugstores's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
China Jo-Jo Drugstores's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.9 million.
The EBITDA is a measure of a China Jo-Jo Drugstores's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $133.1 million |
|---|---|
| Gross profit TTM | $29.2 million |
| Return on assets TTM | -5.23% |
| Return on equity TTM | -38.79% |
| Profit margin | -6.1% |
| Book value | $0.62 |
| Market capitalisation | $15 million |
TTM: trailing 12 months
We're not expecting China Jo-Jo Drugstores to pay a dividend over the next 12 months.
China Jo-Jo Drugstores's shares were split on a 1:2 basis on 13 April 2010. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your China Jo-Jo Drugstores shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for China Jo-Jo Drugstores shares which in turn could have impacted China Jo-Jo Drugstores's share price.
Over the last 12 months, China Jo-Jo Drugstores's shares have ranged in value from as little as $0.35 up to $1.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while China Jo-Jo Drugstores's is 0.3984. This would suggest that China Jo-Jo Drugstores's shares are less volatile than average (for this exchange).
China Jo-Jo Drugstores, Inc. , together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.